Robert Preissner
Charité - Universitätsmedizin Berlin
H-index: 56
Europe-Germany
Top articles of Robert Preissner
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Exogenous Estrogen in the Development of Head and Neck Cancer | JAMA Otolaryngology–Head & Neck Surgery | Christian Doll Elena Hofmann Robert Preissner Max Heiland Ute Seeland | 2024/3/28 |
Beneficial Effect of Metformin on the Five-Year Survival in about 40,000 Patients with Head and Neck Cancer | Cancers | Florian Gaertner Saskia Preissner Max Heiland Robert Preissner Jonas Wüster | 2024/2/28 |
Cellular Mechanisms Underlying the Pathogenetic Role of the Primary Cilium in Pulmonary Arterial Hypertension | A Melnikov PD Solymosi P Pennitz JC Schupp G Nouailles | 2024/5 | |
Withdrawn 2.0—update on withdrawn drugs with pharmacovigilance data | Nucleic Acids Research | Kathleen Gallo Andrean Goede Oliver-Andreas Eckert Bjoern-Oliver Gohlke Robert Preissner | 2024/1/5 |
Data-driven analysis of chemicals, proteins and pathways associated with peanut allergy: from molecular networking to biological interpretation | Food Science and Human Wellness | Emmanuel Kemmler Julian Braun Florent Fauchère Sabine Dölle-Bierke Kirsten Beyer | 2024/5/1 |
Association of Herpes simplex infection with significantly increased risk of head and neck cancer: real‐world evidence of about 500,000 patients | International Journal of Dermatology | Jennifer von Stebut Max Heiland Robert Preissner Carsten Rendenbach Saskia Preissner | 2024/4/21 |
Non-animal models for blood–brain barrier permeability evaluation of drug-like compounds | Scientific Reports | Frederic O Dehnbostel Vaibhav A Dixit Robert Preissner Priyanka Banerjee | 2024/4/17 |
The risk of oral squamous cell carcinoma in patients with and without somatoform disorders including bruxism: A retrospective evaluation of 309,278 individuals | Frontiers in Oncology | Marlene Heym Max Heiland Robert Preissner Christopher Huebel Susanne Nahles | 2023/1/9 |
Real-world evidence for beneficial effects of dipyrone in 4,278 patients with pulmonary hypertension–Analysis of the risk of ventilation, hospitalization, and agranulocytosis | European Journal of Pharmacology | Moritz Hertel Saskia Preissner Björn O Gohlke Wolfgang M Kuebler Gema Hernandez | 2023/3/15 |
The Impact of Drug–Drug Interactions on the Toxicity Profile of Combined Treatment with BRAF and MEK Inhibitors in Patients with BRAF-Mutated Metastatic Melanoma | Cancers | Silvia Mezi Andrea Botticelli Simone Scagnoli Giulia Pomati Giulia Fiscon | 2023/9/15 |
Statin Medication Improves Five-Year Survival Rates in Patients with Head and Neck Cancer: A Retrospective Case-Control Study of about 100,000 Patients | Cancers | Jonas Wüster Max Heiland Susanne Nahles Robert Preissner Saskia Preissner | 2023/6/7 |
SuperNatural 3.0—a database of natural products and natural product-based derivatives | Nucleic Acids Research | Kathleen Gallo Emanuel Kemmler Andrean Goede Finnja Becker Mathias Dunkel | 2023/1/6 |
Increased incidence of adult-onset Still’s disease in association with COVID-19 vaccination and SARS-CoV-2 infection | Orphanet Journal of Rare Diseases | Maxime N Gottschalk Max Heiland Susanne Nahles Robert Preissner William A Petri | 2023/3/10 |
Machine Learning and Pharmacogenomics at the Time of Precision Psychiatry | Antonio D Casale Giuseppe Sarli Paride Bargagna Lorenzo Polidori Alessandro Alcibiade | 2023/12/1 | |
Cystic fibrosis transmembrane conductance regulator potentiators attenuate platelet activation and aggregation in blood of healthy donors and COVID-19 patients | Szandor Simmons Erik Asmus Weronika Karle Markus Brack Corey Wittig | 2023/5/23 | |
Abstract P1-11-13: DE-REAL: ITALIAN MULTICENTER EXPERIENCE OF TRASTUZUMAB DERUXTECAN IN A REAL WORLD SETTING | Cancer Research | Andrea Botticelli Simone Scagnoli Simona Pisegna Daniele Santini Antonella Palazzo | 2023/3/1 |
Worse prognosis in females with new onset of depression after oral cancer diagnosis: a retrospective case-control study | Frontiers in Oncology | Elena Hofmann Christian Doll Alize Rogge Robert Preissner Max Heiland | 2023 |
DRD2, DRD3, and HTR2A single-nucleotide polymorphisms involvement in high treatment resistance to atypical antipsychotic drugs | Biomedicines | Antonio Del Casale Maurizio Simmaco Martina Nicole Modesti Clarissa Zocchi Jan Francesco Arena | 2023/7/24 |
224P Clinical features and outcomes in HER2+ mBC patients treated with trastuzumab deruxtecan: A subgroup analysis of the De-REAL study | ESMO Open | A Botticelli S Scagnoli S Pisegna D Santini M De Laurentiis | 2023/5/1 |
Sema7A and Sema4D Heterodimerization is Essential for Membrane Targeting and Neocortical Wiring | bioRxiv | Paraskevi Bessa Andrew G Newman Kuo Yan Theres Schaub Rike Dannenberg | 2023/2/10 |
Co-Authors
